CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era.

导出 LinkOut

翻译打印收藏纠错

第一作者： John L,Vaughn

第一单位： Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

作者： John L,Vaughn ^[1] ; Samantha,Brown ^[2] ; Esperanza B,Papadopoulos ^[3] ; Ann A,Jakubowski ^[3] ; Roni,Tamari ^[3] ; Sergio A,Giralt ^[3] ; Doris M,Ponce ^[3] ; Christina,Cho ^[3] ; Miguel-Angel,Perales ^[3] ; Brian C,Shaffer ^[3] ; Boglarka,Gyurkocza ^[4]

作者单位： Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[1] Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[2] Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.;Department of Medicine, Weill Cornell Medical College, New York, NY, USA. ^[3] Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. gyurkocb@mskcc.org.;Department of Medicine, Weill Cornell Medical College, New York, NY, USA. gyurkocb@mskcc.org. ^[4]

主题词人类(Humans);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);造血干细胞移植(Hematopoietic Stem Cell Transplantation);抗原, CD34(Antigens, CD34);蛋白激酶抑制剂(Protein Kinase Inhibitors)

DOI 10.1038/s41409-022-01783-7

PMID 36076011

发布时间 2022-11-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交